Israeli Galilee Research Institute’s (MIGAL) oral vaccine

[link to www.jpost.com (secure)]

There was a lot of press on this back in April/May but then it's been very quite.

Galilee Research Institute’s (MIGAL) is developing an oral vaccine that uses a harmless bacterial carrier. It works at basically room temperature, can be transported and easily administered. I don't think it uses any significant adjuncts and is not mRNA.

Anyone have any updated information on this? I know they were targetting more mid-2021 and did not seem to be in a hurry as they seemed to want to follow the right process and not 'rush' a vaccine.